Clinical Trial Update: A Study of AV0328 Administered to Healthy Adult Volunteers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for AV0328 in healthy adults evaluating PNAG-expressing pathogenic microbes vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pnag-expressing Pathogenic Microbes Infection

Drugs mentioned

• AV0328

Snippet

Sponsor: Alopexx Vaccine, LLC | Conditions: PNAG-expressing Pathogenic Microbes Vaccine | Phase 1, Phase 2 | Status: COMPLETED